Drug intelligence / Profile preview

porcine reproductive and respiratory syndrome and streptococcus suis bivalent inactivated vaccine

Development stage
Unknown
Lead developer
Shenlian Biotech
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

This bivalent inactivated vaccine, developed by Shen Lian Biotech, is designed to provide simultaneous protection against Porcine Reproductive and Respiratory Syndrome (PRRS) and Streptococcosis in swine. The vaccine contains inactivated antigens from the PRRS virus (specifically the CH-1a strain) and *Streptococcus suis* (specifically the SS2-H strain). By combining these two major porcine pathogens into a single formulation, the vaccine reduces the number of required immunizations, thereby lowering animal stress and labor costs for producers. It is primarily indicated for the prevention of respiratory distress, reproductive failure, and systemic streptococcal infections in pigs. The vaccine works by inducing a humoral and cellular immune response against both the viral and bacterial components, providing broad protection against common strains found in the field.

Other names
猪繁殖与呼吸综合征、猪链球菌病二联灭活疫苗链球菌/蓝耳病二联疫苗Streptococcus suis and PRRSV bivalent vaccinePRRSV and Streptococcus suis bivalent inactivated vaccine

Beyond the preview

Go deeper on porcine reproductive and respiratory syndrome and streptococcus suis bivalent inactivated vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on porcine reproductive and respiratory syndrome and streptococcus suis bivalent inactivated vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call